174 related articles for article (PubMed ID: 30050301)
1. Frontal lobe metabolic alterations in autism spectrum disorder: a
Margari L; De Giacomo A; Craig F; Palumbi R; Peschechera A; Margari M; Picardi F; Caldarola M; Maghenzani MA; Dicuonzo F
Neuropsychiatr Dis Treat; 2018; 14():1871-1876. PubMed ID: 30050301
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance spectroscopy features of the thalamus and the cerebellum and their association with clinical features in children with autism spectrum disorder: a prospective study.
Kang QQ; Li X; Tong GL; Fan YL; Shi L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Dec; 23(12):1250-1255. PubMed ID: 34911608
[TBL] [Abstract][Full Text] [Related]
3. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.
Libero LE; Reid MA; White DM; Salibi N; Lahti AC; Kana RK
Autism Res; 2016 Jun; 9(6):643-57. PubMed ID: 26526126
[TBL] [Abstract][Full Text] [Related]
4. [Proton magnetic resonance spectroscopy in children with atypical autism comorbid with psychomotor disinhibition syndrome].
Grechanyi SV; Suf El-Zhil LR; Ivanov DO; Pozdnyakova OF; Sergeev AM; Atamanova EE; Pozdnyakov AV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11. Vyp. 2):12-18. PubMed ID: 35038841
[TBL] [Abstract][Full Text] [Related]
5. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
[TBL] [Abstract][Full Text] [Related]
7. Atypical developmental patterns of brain chemistry in children with autism spectrum disorder.
Corrigan NM; Shaw DW; Estes AM; Richards TL; Munson J; Friedman SD; Dawson G; Artru AA; Dager SR
JAMA Psychiatry; 2013 Sep; 70(9):964-74. PubMed ID: 23903694
[TBL] [Abstract][Full Text] [Related]
8. Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study.
Moon CM; Jeong GW
Magn Reson Imaging; 2016 May; 34(4):429-36. PubMed ID: 26708039
[TBL] [Abstract][Full Text] [Related]
9. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
[TBL] [Abstract][Full Text] [Related]
10. Gray and white matter brain chemistry in young children with autism.
Friedman SD; Shaw DW; Artru AA; Dawson G; Petropoulos H; Dager SR
Arch Gen Psychiatry; 2006 Jul; 63(7):786-94. PubMed ID: 16818868
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
12. 1H-MRS in autism spectrum disorders: a systematic meta-analysis.
Ipser JC; Syal S; Bentley J; Adnams CM; Steyn B; Stein DJ
Metab Brain Dis; 2012 Sep; 27(3):275-87. PubMed ID: 22426803
[TBL] [Abstract][Full Text] [Related]
13. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
14. Preliminary MRS study of critical values of relevant brain metabolites in elderly Chinese patients with post-stroke cognitive impairment.
Li M; Yao L; Lu Z; Yang L; Fan H
IBRO Neurosci Rep; 2023 Dec; 15():287-292. PubMed ID: 37885832
[TBL] [Abstract][Full Text] [Related]
15. Metabolite alterations in autistic children: a 1H MR spectroscopy study.
Kubas B; Kułak W; Sobaniec W; Tarasow E; Lebkowska U; Walecki J
Adv Med Sci; 2012 Jun; 57(1):152-6. PubMed ID: 22472469
[TBL] [Abstract][Full Text] [Related]
16. Detection and application of neurochemical profile by multiple regional
Guan J; Rong Y; Wen Y; Wu H; Qin H; Zhang Q; Chen W
Brain Behav; 2017 Sep; 7(9):e00792. PubMed ID: 28948086
[TBL] [Abstract][Full Text] [Related]
17. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
18. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [¹H]MRS study.
Horder J; Lavender T; Mendez MA; O'Gorman R; Daly E; Craig MC; Lythgoe DJ; Barker GJ; Murphy DG
Transl Psychiatry; 2013 Jul; 3(7):e279. PubMed ID: 23838890
[TBL] [Abstract][Full Text] [Related]
19. A proton spectroscopy study of white matter in children with autism.
Hardan AY; Fung LK; Frazier T; Berquist SW; Minshew NJ; Keshavan MS; Stanley JA
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():48-53. PubMed ID: 26593330
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review of the (1)H-MRS Metabolite Spectrum in Autism Spectrum Disorder.
Ford TC; Crewther DP
Front Mol Neurosci; 2016; 9():14. PubMed ID: 27013964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
